Anlon Healthcare

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
151.90
-1.5 (-0.98%)
BSENSE

Dec 05

BSE+NSE Vol: 54.92 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 37.90%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 102.20%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 38.27%

stock-summary

Interest

Growth in half year ended Sep 2025 is -12.04%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Anlon Healthcare With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
85.50
372.36
-286.86
-77.04%
Other Operating Income
0.00
0.00
0.00
Total Operating income
85.50
372.36
-286.86
-77.04%
Raw Material Cost
70.42
255.42
-185.00
-72.43%
Purchase of Finished goods
0.00
44.89
-44.89
-100.00%
(Increase) / Decrease In Stocks
-13.24
-3.15
-10.09
-320.32%
Employee Cost
2.29
13.04
-10.75
-82.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
6.05
39.99
-33.94
-84.87%
Total Expenditure (Excl Depreciation)
65.52
350.19
-284.67
-81.29%
Operating Profit (PBDIT) excl Other Income
19.98
22.17
-2.19
-9.88%
Other Income
0.04
4.37
-4.33
-99.08%
Operating Profit (PBDIT)
20.02
26.54
-6.52
-24.57%
Interest
1.68
0.29
1.39
479.31%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
18.34
26.25
-7.91
-30.13%
Depreciation
0.88
5.38
-4.50
-83.64%
Profit Before Tax
17.45
20.87
-3.42
-16.39%
Tax
4.59
4.96
-0.37
-7.46%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
12.86
15.91
-3.05
-19.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
12.86
15.91
-3.05
-19.17%
Equity Capital
53.15
50.11
3.04
6.07%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
2.42
1.59
0.83
52.20%
Diluted Earnings per share
3.07
1.59
1.48
93.08%
Operating Profit Margin (Excl OI)
23.37%
5.95%
0.00
17.42%
Gross Profit Margin
21.45%
7.05%
0.00
14.40%
PAT Margin
15.04%
4.27%
0.00
10.77%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 85.50 Cr
in Sep 2025

Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 12.86 Cr
in Sep 2025

Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.98 Cr
in Sep 2025

Figures in Cr
Half Yearly - Interest
Interest 1.68 Cr
in Sep 2025

Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.37%
in Sep 2025

Figures in %